MedPath

Routine Follow-up Versus Self-assessment in Medical Abortion

Not Applicable
Completed
Conditions
Medical Abortion
Interventions
Other: Home self assessment of complete medical abortion
Registration Number
NCT01487213
Lead Sponsor
Karolinska Institutet
Brief Summary

The main objective of the study is to optimize the routines for follow-up after medical abortion in order to give women more autonomy by reducing the number of consultations involved and to reduce the frequency of postabortal curettage.

This will be achieved by providing means for women for postabortal self-assessment with the use of a quantitative urinary hCG test.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
929
Inclusion Criteria
  • women requesting termination of pregnancy by means of mifepristone followed by home administration of misoprostol at < /=63 days of gestation, with no contraindication to medical abortion and self administration of misoprostol at home, and who have given their informed consent will be eligible for study recruitment.
Exclusion Criteria
  • women who do not wish to participate
  • women who do not want home administration of misoprostol
  • women who are unable to communicate in Swedish, Norwegian, English, Finnish or German and women with symptoms and signs of ectopic pregnancy
  • minors (i.e. women < 18 years of age) will not be enrolled for the study.
  • women seeking termination of pregnancy with no sign of a visible intrauterine pregnancy (i.e. visible intrauterine yolk sac).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Home self testHome self assessment of complete medical abortionIntervention
Primary Outcome Measures
NameTimeMethod
Number of complete abortionsUntil 3 months post treatment

The primary objective is thus to demonstrate the non-inferiority of self-assessment of complete abortion following medical abortion compared to routine follow-up in terms of the percentage of women requiring surgical abortion, within a margin of non-inferiority of 5%.

Secondary Outcome Measures
NameTimeMethod
adverse eventsutil 3 months post treatment

Number of women reporting adverse events and side effects including infections, bleeding, pain

postabortion contraceptionuntil 12 months post treatment

The use of contraception and rate of repeat abortion at follow-up questionnaire at one year.

Trial Locations

Locations (4)

Dept. Obstetrics and Gynaecology,Helsinki University Central Hospital

🇫🇮

Helsinki, Finland

GynMed Clinic

🇦🇹

Vienna, Austria

Faculty of Medicine, University of Oslo and Dept. of Gynaecology,

🇳🇴

Oslo, Norway

Dept of Obstetrics and Gynecology, Karolinska University Hospital

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath